NPPES file of Aug 9, 2026

Mark W. Johnson, MD

Pulmonary Disease Physician · Lubbock, TX

Mark W. Johnson, MD is a pulmonary disease physician with a practice address in Lubbock, Texas, and NPI 1205838653, issued on Aug 15, 2005. Check the license (Texas F9626, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1205838653
Name
Mark W. Johnson
Credential
MD
Primary taxonomy
Pulmonary Disease Physician 207RP1001X
License number
F9626 TX
Self-reported in NPPES; status is on the state search
Practice location
3621 22ND St, Lubbock, TX 79410
Phone
(806) 791-8484
Enumerated
Aug 15, 2005
Record last updated
Oct 12, 2011 (not updated in 15 years: call before relying on the address or phone)
Fax
(806) 791-8484
Medicaid ID
132871806 TX
Medicare enrollment
Enrolled (PECOS I20091112000483); accepts Medicare assignment
Medical or professional school
University Of Minnesota Medical School, 1978
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 3621 22ND St

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Naidu Chekuru, MDPulmonary Disease Physician1073515433
  2. Gloria Cleveland, AU. D.Audiologist1760657464
  3. Michelle Coffey, AGACNP-BCAcute Care Nurse Practitioner1417407149
  4. Lauren HullumAcute Care Nurse Practitioner1619638301
  5. Srinivas Kadiyala, MDPulmonary Disease Physician1275535635
  6. Thomas Neal, M.D.Otolaryngology Physician1043259112

Verify Mark W. Johnson in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersTexas Medical Board
    Search for license F9626
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Texas license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

86% more Medicare Part D claims than the average pulmonary disease physician in 2024

2,647 Medicare Part D claims for 320 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 52% of claims.

  1. Mark Johnson2,647
  2. Specialty average1,425

Most prescribed

  1. Trelegy Ellipta511 claims
  2. Prednisone335 claims
  3. Albuterol Sulfate Hfa280 claims
  4. Montelukast Sodium191 claims
  5. Doxycycline Hyclate169 claims
  6. Breztri Aerosphere114 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $1,562.60

83 payments; by number, the most common kind was food and beverage; the largest payer was GlaxoSmithKline, LLC. The 8,806 providers of this specialty with any payment received $5,159.88 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Mark Johnson$1,562.60
  2. Specialty average$5,159.88

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Covenant Medical GroupSnyder, TX

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Pulmonary Disease Physician providers in Texas

There are 967 pulmonary disease physician records in Texas.

Other pulmonary disease physician records in Texas

  1. Olaedo Abana, MDWaco, TX1326544529
  2. Qammar Abbas, M.D.Wylie, TX1720359680
  3. Mohamed Abdalla, MDSan Antonio, TX1528413598
  4. Ali Abedi, M.D.San Antonio, TX1346566312
  5. Ricardo Abreu, MDWeslaco, TX1265469803
  6. Emran Abu Atherah, M.DWebster, TX1356570220
  7. Muhanned Abu-Hijleh, M.D.Texarkana, TX1730133190
  8. Sherif Abuserewa, MDLubbock, TX1801450630
  9. Bruce Ackerman, D.O.Garland, TX1932136785
  10. Mari Adachi, MDPlano, TX1104928340

Common questions

What is Mark W. Johnson, MD's NPI number?

Mark W. Johnson, MD's National Provider Identifier (NPI) is 1205838653, issued on Aug 15, 2005. An NPI identifies a provider in billing; it is not a license.

Where is Mark W. Johnson, MD located?

The NPPES record lists a practice address at 3621 22ND St, Lubbock, TX, 79410. Phone: (806) 791-8484. Providers update this record themselves, so call before visiting.

How can I verify Mark W. Johnson, MD's license?

NPPES lists Texas license number F9626, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Mark W. Johnson, MD prescribe under Medicare Part D?

In 2024, Mark W. Johnson, MD had 2,647 Medicare Part D claims for 320 beneficiaries; the average among pulmonary disease physician prescribers was 1,425. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.